Debra Frei‐Lahr

673 total citations
18 papers, 487 citations indexed

About

Debra Frei‐Lahr is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Debra Frei‐Lahr has authored 18 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Genetics and 5 papers in Immunology. Recurrent topics in Debra Frei‐Lahr's work include Blood groups and transfusion (5 papers), Complement system in diseases (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Debra Frei‐Lahr is often cited by papers focused on Blood groups and transfusion (5 papers), Complement system in diseases (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Debra Frei‐Lahr collaborates with scholars based in United States, Japan and Pakistan. Debra Frei‐Lahr's co-authors include Randy A. Brown, Geoffrey P. Herzig, John Hayslip, Philip D. Hall, Philip D. Hall, Anne McDonnell, C.F. LeMaistre, Joseph W. Fay, Leonard Giannone and Steven N. Wolff and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Hematology.

In The Last Decade

Debra Frei‐Lahr

18 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debra Frei‐Lahr United States 9 192 128 128 115 111 18 487
Marion Sternbach Canada 10 263 1.4× 126 1.0× 138 1.1× 126 1.1× 50 0.5× 17 529
J Akatsuka Japan 14 403 2.1× 112 0.9× 102 0.8× 109 0.9× 98 0.9× 43 734
Anna Pawłowska United States 11 125 0.7× 95 0.7× 129 1.0× 124 1.1× 63 0.6× 44 465
Gabrielle Meyers United States 15 334 1.7× 124 1.0× 174 1.4× 85 0.7× 41 0.4× 43 602
SJ Goldman United States 9 223 1.2× 166 1.3× 267 2.1× 143 1.2× 101 0.9× 12 595
Jeffrey Jacobsen United States 7 206 1.1× 165 1.3× 113 0.9× 101 0.9× 74 0.7× 10 502
L. Clifford McKee United States 10 222 1.2× 90 0.7× 111 0.9× 72 0.6× 59 0.5× 15 482
E Vassallo Italy 11 150 0.8× 66 0.5× 91 0.7× 60 0.5× 99 0.9× 26 379
Isabelle Radford France 11 200 1.0× 71 0.6× 152 1.2× 103 0.9× 23 0.2× 18 517
M. van Weel Netherlands 5 195 1.0× 101 0.8× 21 0.2× 152 1.3× 63 0.6× 7 439

Countries citing papers authored by Debra Frei‐Lahr

Since Specialization
Citations

This map shows the geographic impact of Debra Frei‐Lahr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra Frei‐Lahr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra Frei‐Lahr more than expected).

Fields of papers citing papers by Debra Frei‐Lahr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra Frei‐Lahr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra Frei‐Lahr. The network helps show where Debra Frei‐Lahr may publish in the future.

Co-authorship network of co-authors of Debra Frei‐Lahr

This figure shows the co-authorship network connecting the top 25 collaborators of Debra Frei‐Lahr. A scholar is included among the top collaborators of Debra Frei‐Lahr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra Frei‐Lahr. Debra Frei‐Lahr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
McDonnell, Anne, et al.. (2006). Single‐Dose Rasburicase 6 mg in the Management of Tumor Lysis Syndrome in Adults. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(6). 806–812. 60 indexed citations
3.
Inoue, Naoya, Yoshiko Murakami, Yushiro Endo, et al.. (2006). Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH). Blood. 108(13). 4232–4236. 91 indexed citations
4.
Frei‐Lahr, Debra, Norimitsu Inoue, Carl T. Wittwer, et al.. (2006). Molecular Complete Remission of Clonal Hematopoiesis in Paroxysmal Nocturnal Hemoglobinuria (PNH) after Syngeneic Transplantation.. Blood. 108(11). 5362–5362. 1 indexed citations
5.
Frei‐Lahr, Debra, et al.. (2005). Treatment of Acute Myeloid Leukemia During the Second and Third Trimesters of Pregnancy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(8). 1134–1140. 36 indexed citations
6.
Inoue, Norimitsu, Yuichi Endo, Jun‐ichi Nishimura, et al.. (2005). Clonal Expansion in Paroxysmal Nocturnal Hemoglobinuria (PNH): Expression of Mutant HMGA2 Suggests That PNH Is a Benign Tumor of the Bone Marrow.. Blood. 106(11). 3533–3533. 1 indexed citations
7.
Onitilo, Adedayo A., et al.. (2003). Autologous bone marrow transplant in a patient with sickle cell disease and diffuse large B-cell lymphoma. Transplantation Proceedings. 35(8). 3089–3092. 8 indexed citations
8.
Frei‐Lahr, Debra, et al.. (2002). Primary Mediastinal Large B-cell Lymphoma. Southern Medical Journal. 95(9). 1005–1007. 1 indexed citations
9.
Schuster, Michael W., Roy Beveridge, Debra Frei‐Lahr, et al.. (2002). The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation. Experimental Hematology. 30(9). 1044–1050. 24 indexed citations
10.
Frei‐Lahr, Debra, et al.. (2002). Primary Mediastinal Large B-cell Lymphoma. Southern Medical Journal. 95(9). 1005–1007. 1 indexed citations
11.
Ryan, Michael T., et al.. (2000). Health Physics Consequences of Out-Patient Treatment of Non-Hodgkinʼs Lymphoma with 131I-radiolabeled Anti-B1 Antibody. Health Physics. 79(Supplement). S52–S55. 7 indexed citations
12.
Ross, Ryan E., et al.. (1998). Transfusion management of an IgA deficient patient with anti-IgA and incidental correction of IgA deficiency after allogeneic bone marrow transplantation. American Journal of Hematology. 57(4). 326–330. 3 indexed citations
13.
Frei‐Lahr, Debra, et al.. (1991). Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation. Journal of Clinical Apheresis. 6(1). 16–20. 48 indexed citations
14.
Ratner, Lee, Nancy Vander Heyden, Elizabeth Paine, et al.. (1990). Familial adult T‐cell leukemia/lymphoma. American Journal of Hematology. 34(3). 215–222. 10 indexed citations
15.
Wolff, Steven N., Roger H. Herzig, Joseph W. Fay, et al.. (1990). High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies.. PubMed. 17(1 Suppl 3). 2–6. 78 indexed citations
16.
17.
Brown, R.A., RH Herzig, SN Wolff, et al.. (1990). High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy. Blood. 76(3). 473–479. 5 indexed citations
18.
Wolff, Steven N., R H Herzig, Joseph W. Fay, et al.. (1989). High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation Group.. Journal of Clinical Oncology. 7(2). 245–249. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marion Sternbach Breakdown of academic impact, for papers by J Akatsuka Breakdown of academic impact, for papers by Anna Pawłowska Breakdown of academic impact, for papers by Gabrielle Meyers Breakdown of academic impact, for papers by SJ Goldman Breakdown of academic impact, for papers by Jeffrey Jacobsen Breakdown of academic impact, for papers by L. Clifford McKee Breakdown of academic impact, for papers by E Vassallo Breakdown of academic impact, for papers by Isabelle Radford Breakdown of academic impact, for papers by M. van Weel
Rankless by CCL
2026